Skip to Content

News & Events

Show:

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on...

READ MORE

Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference

SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on...

READ MORE

Event With Webcast Template – ATTENTION INTRADO

ACROBAT Edge Phase 2 interim results and corporate update.

READ MORE

Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference 2020

SAN DIEGO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on...

READ MORE

Crinetics Pharmaceuticals to Participate in the Piper Jaffray Healthcare Conference

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX announced that Scott Struthers, Ph.D., Founder and Chief Executive Officer, will participate in a fireside...

READ MORE

Crinetics Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on...

READ MORE

Crinetics Pharmaceuticals to Participate in Cantor Global Healthcare Conference

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) announced that Scott Struthers, Ph.D., Founder and Chief Executive Officer, will participate in a fireside...

READ MORE